624 related articles for article (PubMed ID: 17716187)
1. Ocular drug delivery: nanomedicine applications.
Vandervoort J; Ludwig A
Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
[TBL] [Abstract][Full Text] [Related]
2. Functionalized gold nanoparticles for drug delivery.
Han G; Ghosh P; Rotello VM
Nanomedicine (Lond); 2007 Feb; 2(1):113-23. PubMed ID: 17716197
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional nanocarriers.
Torchilin VP
Adv Drug Deliv Rev; 2006 Dec; 58(14):1532-55. PubMed ID: 17092599
[TBL] [Abstract][Full Text] [Related]
4. Use of degradable and nondegradable nanomaterials for controlled release.
Wan WK; Yang L; Padavan DT
Nanomedicine (Lond); 2007 Aug; 2(4):483-509. PubMed ID: 17716133
[TBL] [Abstract][Full Text] [Related]
5. Liposomal drug delivery systems: from concept to clinical applications.
Allen TM; Cullis PR
Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
[TBL] [Abstract][Full Text] [Related]
6. Nanotherapy for posterior eye diseases.
Kaur IP; Kakkar S
J Control Release; 2014 Nov; 193():100-12. PubMed ID: 24862316
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
[TBL] [Abstract][Full Text] [Related]
8. Real-time electrochemical monitoring of drug release from therapeutic nanoparticles.
Mora L; Chumbimuni-Torres KY; Clawson C; Hernandez L; Zhang L; Wang J
J Control Release; 2009 Nov; 140(1):69-73. PubMed ID: 19679152
[TBL] [Abstract][Full Text] [Related]
9. Micro- and nanoparticles--medical applications.
Jătariu A; Peptu C; Popa M; Indrei A
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
[TBL] [Abstract][Full Text] [Related]
10. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
Reis CP; Neufeld RJ; Ribeiro AJ; Veiga F
Nanomedicine; 2006 Mar; 2(1):8-21. PubMed ID: 17292111
[TBL] [Abstract][Full Text] [Related]
11. Nanoemulsion: An Advanced Vehicle For Efficient Drug Delivery.
Ali A; Ansari VA; Ahmad U; Akhtar J; Jahan A
Drug Res (Stuttg); 2017 Nov; 67(11):617-631. PubMed ID: 28738427
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
13. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
GuhaSarkar S; Banerjee R
J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
[TBL] [Abstract][Full Text] [Related]
14. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
[TBL] [Abstract][Full Text] [Related]
15. Integration column: biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications.
Rothenfluh DA; Hubbell JA
Integr Biol (Camb); 2009 Jul; 1(7):446-51. PubMed ID: 20023754
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.
Soares AF; Carvalho Rde A; Veiga F
Nanomedicine (Lond); 2007 Apr; 2(2):183-202. PubMed ID: 17716120
[TBL] [Abstract][Full Text] [Related]
17. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
Moritz M; Geszke-Moritz M
Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
Narang AS; Chang RK; Hussain MA
J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
[TBL] [Abstract][Full Text] [Related]
20. Why I believe nanoparticles are crucial as a carrier for targeted drug delivery.
Baker JR
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):423-9. PubMed ID: 23633301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]